carvedilol has been researched along with Mastocytosis in 1 studies
Mastocytosis: A rare neoplastic disorder characterized by a clonal proliferation of MAST CELLS, associated with KIT-D816 mutations, and accompanied by aberrant mast cell activation. The abnormal increase of MAST CELLS may occur in only the skin (MASTOCYTOSIS, CUTANEOUS), in extracutaneous tissues involving multiple organs (MASTOCYTOSIS, SYSTEMIC), or in solid tumors (MASTOCYTOMA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robertson, LM | 1 |
| Frith, JA | 1 |
| Tcheurekdjian, H | 1 |
| Hostoffer, RW | 1 |
1 other study available for carvedilol and Mastocytosis
| Article | Year |
|---|---|
Possible mast cell activation syndrome in a patient undergoing long-term hemodialysis.
Topics: Aged; Amlodipine; Anaphylaxis; Carbazoles; Carvedilol; Community-Acquired Infections; Deglutition Di | 2016 |